Primrose Bio exhibited at PEGS Boston 2025 from May 12–16, highlighting advancements in complex protein development powered by our proprietary Pfenex Expression Technology® and Pfast™ Feasibility platform.
On May 12, Russell Coleman delivered a featured lunch presentation:
“Pfast™ Protein Expression: A Rapid, Robust Solution for Accelerating Biotherapeutic Screening,” demonstrating how our 10-day evaluation program helps de-risk early-stage development.
Jeff Allen also presented Poster A079:
“High-Throughput Expression and Purification of Untagged RNA Polymerase Variants: Advancements in the Pfenex Expression Technology® Platform,” showcasing the power and flexibility of our microbial expression system.
With six approved commercial products leveraging Pfenex, and a growing track record of success, we were proud to connect with innovators across the biotherapeutics field at Booth #624.
